Keyphrases
Adverse Drug Reaction
100%
Reason for Admission
55%
Adverse Reactions to Medications
50%
Antiarrhythmic Drugs
50%
Emergency Room
50%
Oral Contraceptive Therapy
50%
Propafenone
50%
Pulmonary Embolism
50%
Heart Failure
50%
Inappropriate Use
50%
Intensive Care Unit
50%
Bradycardia
50%
High Risk
50%
Venous Stasis
25%
Safety Problems
25%
Drospirenone
25%
Hypercoagulability
25%
CT Angiography
25%
Serious Adverse Reaction
25%
Channel Blockage
25%
Anticoagulants
25%
Severe Adverse Events
25%
Anticardiolipin
25%
Ethinylestradiol
25%
Vascular Lesions
25%
Pharmaceutical Services
25%
Enoxaparin
25%
Sodium Channel
25%
Elderly Patients
25%
Coagulation Factors
25%
Warfarin
25%
Lupus Anticoagulant
25%
Medication Errors
25%
Oral Contraceptives
25%
Combined Oral Contraceptives
25%
Drug Class
25%
Young Female
25%
Non-pharmacological
25%
Supraventricular Tachycardia
25%
Confidence Interval
22%
Preventability
22%
Clinical Classification
22%
Indexed Journals
16%
Number of Patients
16%
Pharmacology
16%
Descriptive Cross-sectional Study
16%
Emergency Medicine
16%
Mayors
16%
Medical Records
16%
Acetylsalicylic Acid
5%
Bradyarrhythmia
5%
Classification Standard
5%
Losartan
5%
Intensive Care Unit Admission
5%
Naranjo Algorithm
5%
Classification Basis
5%
Thorntons
5%
Upper Gastrointestinal Bleeding
5%
Inclusion Criteria
5%
Therapeutic Range
5%
Clinical Impact
5%
Comorbidity
5%
University Hospital
5%
Therapeutic Failure
5%
Clinical Records
5%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
100%
Adverse Drug Reaction
100%
Lung Embolism
50%
Thromboembolism
50%
Antiarrhythmic Agent
50%
Propafenone
50%
Congestive Heart Failure
50%
Oral Contraceptive
50%
Ethinylestradiol
25%
Venous Stasis
25%
Lupus Anticoagulant
25%
Blood Clotting Factor
25%
Warfarin
25%
Oral Contraceptive Agent
25%
Vascular Lesion
25%
Enoxaparin
25%
Drospirenone
25%
Hypercoagulability
25%
Sodium Channel
25%
Anticoagulant Agent
25%
Supraventricular Tachycardia
25%
Medication Error
25%
Physical Disease by Body Function
25%
Cross-Sectional Study
16%
Acetylsalicylic Acid
5%
Upper Gastrointestinal Bleeding
5%
Losartan
5%
Comorbidity
5%